Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL
Status:
Terminated
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the maximum tolerated dose (MTD) in patients with
acute lymphoblastic leukemia (ALL) and to determine the safety and tolerability of increasing
doses and different infusion times of AFM11 infusion in patients with adult B-precursor ALL